UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q4 2021 | 2022-02-23 | Future report Set alerts | |
| Q3 2021 | 2021-11-09 | -0.22 | -0.22 |
| Q2 2021 | 2021-08-09 | -0.53 | -0.53 |
| Q1 2021 | 2021-05-06 | -0.39 | -0.39 |
| Q4 2020 | 2021-02-25 | -0.49 | -0.49 |
| Q3 2020 | 2020-11-05 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-06 | -0.43 | -0.43 |
| Q1 2020 | 2020-05-07 | -0.31 | -0.31 |
| Q4 2019 | 2020-02-27 | -0.58 | -0.58 |
| Q3 2019 | 2019-11-07 | -0.45 | -0.45 |
| 2016-06-30 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-30 | Lower Price Target | Chardan Capital | Neutral | $5.00 to $4.00 |
| 2016-06-30 | Lower Price Target | Stifel Nicolaus | Buy | $16.00 to $13.00 |
| 2016-06-26 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-10 | Lower Price Target | Stifel Nicolaus | Buy | $20.00 to $16.00 |
| 2016-05-10 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-10 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-05-10 | Reiterated Rating | Jefferies Group | Buy | $19.00 |
| 2016-04-14 | Reiterated Rating | Chardan Capital | Neutral | |
| 2016-04-04 | Initiated Coverage | Chardan Capital | Neutral | $5.00 |
| 2016-03-12 | Reiterated Rating | Jefferies Group | Buy | $25.00 to $19.00 |
| 2015-12-28 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-12-22 | Reiterated Rating | Leerink Swann | Outperform | $24.00 to $20.00 |
| 2015-11-11 | Lower Price Target | Leerink Swann | Outperform | $30.00 to $24.00 |
| 2015-11-11 | Lower Price Target | Stifel Nicolaus | Buy | $24.00 to $20.00 |
| 2015-09-08 | Initiated Coverage | Cowen and Company | Outperform | |
| 2015-08-10 | Reiterated Rating | Stifel Nicolaus | Buy | $24.00 |
| 2015-08-07 | Lower Price Target | Leerink Swann | Outperform | $40.00 to $30.00 |
| 2015-05-29 | Initiated Coverage | Jefferies Group | Buy | $46.00 to $25.00 |
| 2015-03-13 | Boost Price Target | Leerink Swann | Outperform | $25.00 to $40.00 |
| 2014-11-07 | Reiterated Rating | Stifel Nicolaus | Buy | $70.00 to $21.00 |
| 2014-08-08 | Lower Price Target | Leerink Swann | $48.00 to $42.00 | |
| 2014-05-14 | Reiterated Rating | Stifel Nicolaus | Buy | $53.00 to $44.00 |
| 2014-05-14 | Lower Price Target | Leerink Swann | Outperform | $60.00 to $48.00 |
| 2014-02-24 | Initiated Coverage | Robert W. Baird | Neutral | $41.00 |
| 2014-02-24 | Initiated Coverage | Leerink Swann | Outperform | $60.00 |
| 2014-02-24 | Initiated Coverage | Stifel Nicolaus | Buy | $53.00 |
| 2014-02-24 | Initiated Coverage | Jefferies Group | Buy |
| 2016-06-30 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-30 | Lower Price Target | Chardan Capital | Neutral | $5.00 to $4.00 |
| 2016-06-30 | Lower Price Target | Stifel Nicolaus | Buy | $16.00 to $13.00 |
| 2016-06-26 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-05-10 | Lower Price Target | Stifel Nicolaus | Buy | $20.00 to $16.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In DRNA 11 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Marshall Wace North America, L.P. | 0.51M |
| TEACHERS ADVISORS INC | 0.12M |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 96414 |
| BlackRock Institutional Trust Company, N.A. | 80368 |
| BlackRock Fund Advisors | 44002 |
| Quotient Investors, LLC | 19300 |
| CHICAGO EQUITY PARTNERS LLC | 14910 |
| Aperio Group, LLC | 13025 |
| BlackRock Investment Management, LLC | 2889 |
| BLACKROCK ADVISORS LLC | 2670 |
| LADENBURG THALMANN FINANCIAL SERVICES INC | 305 |
UM